Transition to Ambulatory Bariatric Surgery (TABS) Trial
NCT ID: NCT07011628
Last Updated: 2025-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
200 participants
INTERVENTIONAL
2026-03-01
2028-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
NCT00721227
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
NCT06162715
The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial
NCT03185949
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
NCT04494048
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
NCT07063979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Same Day Discharge
Patients in the same day discharge will be discharged from the hospital following surgery without an overnight stay in the hospital.
Same Day Discharge
Patients in the same day discharge arm will be discharged from the hospital within 6 hours of arriving to the recovery unit and without an overnight stay in the hospital.
Standard of care - Hospital Admission
Patients in the standard of care arm will be admitted to the hospital for at least one overnight stay in the hospital.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Same Day Discharge
Patients in the same day discharge arm will be discharged from the hospital within 6 hours of arriving to the recovery unit and without an overnight stay in the hospital.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary Sleeve gastrectomy or Gastric Bypass,
* Undergoing bariatric surgery at sponsor site
Exclusion Criteria
* Myocardial Infarction
* Unstable Angina or Heart Failure
* Prior Stroke
* Solid organ transplantation
* Systemic glucocorticoid prior 28 days
* Severe Obstructive Sleep Apnea
* Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90)
* Untreated Hyperthyroidism
* Chronic Kidney Disease (EGFR \< 60)
* Current anticoagulant use,
* Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%)
* Chronic opioid use
* Insulin dependence.
* Need for extended venous thromboembolic event prophylaxis,
* \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
* Patient lives \> 130 miles from the hospital.
* Tobacco use in last 12 months
* Desire to become pregnant or active pregnancy
* Prisoners
* Unable or unwilling to follow-up
* Unable to understand or provide consent
25 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jason Samuels
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
250548
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.